Kamat Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KAMAT
KAMAT has one approved drug.
There is one US patent protecting KAMAT drugs.
Summary for Kamat
| US Patents: | 1 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Kamat
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kamat | RALDESY | trazodone hydrochloride | SOLUTION;ORAL | 218637-001 | Nov 26, 2024 | RX | Yes | Yes | 8,133,893 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Kamat Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 6513911 | ⤷ Start Trial |
| Poland | 2178850 | ⤷ Start Trial |
| Eurasian Patent Organization | 201070228 | ⤷ Start Trial |
| Portugal | 2178850 | ⤷ Start Trial |
| Georgia, Republic of | P20135926 | ⤷ Start Trial |
| Cyprus | 1115666 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
